Funding Rounds

A Subsidiary of Qomel Secures Financing Worth 50.7 Million SAR

Qomel, a Saudi company specializing in pharmaceuticals and medical supplies, announced that its subsidiary, Qomel Factory (a limited liability company), has received approval from the Saudi Industrial Development Fund along with financing worth 50.7 million SAR to establish a pharmaceutical manufacturing plant.

The financing extends for six years, with a grace period of up to six years. The loan will be repaid in 14 semi-annual installments of unequal value, starting on February 15, 2030, according to the agreed-upon repayment schedule.

The company noted that the collateral provided for the financing includes mortgaging all fixed assets related to the project, in addition to providing personal guarantees.

Related Articles

Back to top button